$1.46
0.05[3.55%]
Last update: 4:42AM Get Real Time Here
OKYO Pharma
(NASDAQ:OKYO)Latest News for OKYO Pharma Stock (NASDAQ:OKYO)
OKYO Pharma Stock (NASDAQ: OKYO)
Categories: All
Monday, March 25, 2024
Friday, March 22, 2024
- Relief For Dry Eye Disease? OKYO Pharma's Candidate Shows Durable Pain Relief In Mid-Stage StudyVandana Singh - Mar 22, 2024, 11:53AM
- HC Wainwright & Co. Maintains Buy on OKYO Pharma, Raises Price Target to $7Benzinga Newsdesk - Mar 22, 2024, 11:05AM
- OKYO Pharma shares are trading higher after the company's OK-101 achieved statistical significance for multiple signs and symptoms of dry eye disease in its first-in-human Phase 2 trial.Benzinga Newsdesk - Mar 22, 2024, 7:12AM
- OKYO Pharma Says OK-101 Achieves Statistical Significance For Multiple Signs And Symptoms Of Dry Eye Disease Including Ocular Pain Relief In Its First-in-Human Phase 2 Trial Of OK-101Benzinga Newsdesk - Mar 22, 2024, 7:03AM
Friday, March 01, 2024
Monday, February 12, 2024
Friday, February 09, 2024
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Feb 9, 2024, 12:31PM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Feb 9, 2024, 8:06AM
- The FDA Has Cleared Okyo Pharma's OK-101 As Its First Investigational New Drug Application For The Treatment Of Neuropathic Corneal Pain; Okyo Pharma Is Scheduling This Trial To Begin In Q2 2024Benzinga Newsdesk - Feb 9, 2024, 7:02AM
Monday, January 08, 2024
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga Insights - Jan 8, 2024, 4:31PM
- HC Wainwright & Co. Maintains Buy on OKYO Pharma, Raises Price Target to $5Benzinga Newsdesk - Jan 8, 2024, 8:17AM
- Okyo Pharma Reports Safety And Efficacy Results In Its Phase 2 Trial Of OK-101 Ophthalmic Solution For Dry Eye Disease; The Company Says The Trial Achieved Statistical Significance For Both Sign And Symptom EndpointsBenzinga Newsdesk - Jan 8, 2024, 7:43AM
Tuesday, December 05, 2023
Monday, December 04, 2023
Thursday, November 02, 2023
Tuesday, October 31, 2023
Monday, October 09, 2023
Thursday, October 05, 2023
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Oct 5, 2023, 5:32PM
- Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Oct 5, 2023, 1:22PM
- Dry Eye Disease Affects Around 50M Americans, OKYO Pharma's Candidate Shows Safety In Mid-Stage StudyVandana Singh - Oct 5, 2023, 10:27AM
- Okyo Pharma Announces Safety Data Profile For Ongoing OK-101 Phase 2 Trial For Dry Eye Disease; Patients Continue In The Study, Double-blind Procedures Are Still In Effect Until All Patients Complete The 12-week Dosing Duration; Topline Data In DecemberBenzinga Newsdesk - Oct 5, 2023, 7:11AM
Tuesday, September 19, 2023
Monday, September 18, 2023
Friday, September 15, 2023
Thursday, September 14, 2023
- S&P 500 Reclaims 4,500, Oil Hits $90 As Rising Inflation Fails To Dampen Risk Sentiment: What's Driving Markets Thursday?Shanthi Rexaline - Sep 14, 2023, 1:21PM
- Why Clearmind Medicine Shares Are Trading Lower By 53%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Sep 14, 2023, 12:58PM
- Okyo Pharma Priced Its Registered Direct Offering Of 2.7M Shares At $1.50/Share Conducted Without An Underwriter Or Placement Agent, With Gross Proceeds Of $3.95MBenzinga Newsdesk - Sep 14, 2023, 9:50AM
- OKYO Pharma Limited Announces Withdrawal Of Public OfferingBenzinga Newsdesk - Sep 14, 2023, 8:46AM
- Market-Moving News for September 14thBenzinga Newsdesk - Sep 14, 2023, 8:35AM
- Why Novo Integrated Sciences Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving PremarketLisa Levin - Sep 14, 2023, 8:05AM
Wednesday, September 13, 2023
- 12 Health Care Stocks Moving In Wednesday's After-Market SessionBenzinga Insights - Sep 13, 2023, 5:31PM
- OKYO shares are trading lower after the company announced a $4 million public offering of ordinary shares.Benzinga Newsdesk - Sep 13, 2023, 4:32PM
- OKYO Pharma Announces $4M Public Offering of Ordinary SharesBenzinga Newsdesk - Sep 13, 2023, 4:06PM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Sep 13, 2023, 9:06AM
- Why Mainz Biomed Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving PremarketLisa Levin - Sep 13, 2023, 8:16AM
Friday, September 08, 2023
Thursday, August 31, 2023
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Aug 31, 2023, 1:31PM
- Why Lands' End Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Aug 31, 2023, 12:50PM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Aug 31, 2023, 9:06AM
- Why Okta Shares Are Trading Higher By 11%; Here Are 20 Stocks Moving PremarketLisa Levin - Aug 31, 2023, 8:13AM
Wednesday, August 30, 2023
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Aug 30, 2023, 1:31PM
- OKYO Pharma Limited shares are trading lower. The company announced that it has enrolled and randomized 90% of the patients in its 240-patient Phase 2 clinical trial of OK-101 to treat dry eye disease.Benzinga Newsdesk - Aug 30, 2023, 10:53AM
- Why NanoVibronix Shares Are Trading Higher By 49%; Here Are 20 Stocks Moving PremarketLisa Levin - Aug 30, 2023, 9:14AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Aug 30, 2023, 9:06AM
- OKYO Pharma Achieves 90% Enrollment In 240-Patient Phase 2 Clinical Trial Of OK-101 To Treat Dry Eye DiseaseBenzinga Newsdesk - Aug 30, 2023, 7:04AM